Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ying Hong

Showing results (1061-1070 of 1,220) with videos related to

Pageof 122
Sort By:
Journal of Cancer Research and Clinical Oncology|April 4, 2023
Invasiveness assessment by artificial intelligence against intraoperative frozen section for pulmonary nodules ≤ 3 cmZe-Rui Zhao, Ying-Hong Yu, Zhi-Chao Lin, et al.
Briefings in Bioinformatics|January 29, 2019
Clinical trials, progression-speed differentiating features and swiftness rule of the innovative targets of first-in-class drugsYing Hong Li, Xiao Xu Li, Jia Jun Hong, et al.
Journal of Cancer|March 24, 2020
MicroRNA-19a-3p regulates cell growth through modulation of the PIK3IP1-AKT pathway in hepatocellular carcinomaHai-Xiang Sun, Zhang-Fu Yang, Wei-Guo Tang, et al.
Neural Regeneration Research|October 23, 2019
Protective effects of organic extracts of <i>Alpinia oxyphylla</i> against hydrogen peroxide-induced cytotoxicity in PC12 cellsLi-Hong Duan, Meng Li, Chun-Bao Wang, et al.
Frontiers in Immunology|July 9, 2024
Circulating immune and plasma biomarkers of time to HIV rebound in HIV controllers treated with vesatolimodMohamed Abdel-Mohsen, Steven Deeks, Leila Giron, et al.
Circulation Research|June 19, 2010
Nitro-oleic acid inhibits angiotensin II-induced hypertensionJifeng Zhang, Luis Villacorta, Lin Chang, et al.
International Journal of Oncology|November 15, 2016
Lamp2a is required for tumor growth and promotes tumor recurrence of hepatocellular carcinomaZhen-Bin Ding, Xiu-Tao Fu, Ying-Hong Shi, et al.
Cell Death & Disease|June 30, 2017
MicroRNA-29a induces loss of 5-hydroxymethylcytosine and promotes metastasis of hepatocellular carcinoma through a TET-SOCS1-MMP9 signaling axisQing Chen, Dan Yin, Yong Zhang, et al.
Cancer|September 3, 2015
Role of a serum-based biomarker panel in the early diagnosis of lung cancer for a cohort of high-risk patientsDa-Wei Yang, Yong Zhang, Qun-Ying Hong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2023
A First-in-Human Phase I Study of Milademetan, an MDM2 Inhibitor, in Patients With Advanced Liposarcoma, Solid Tumors, or LymphomasMrinal M Gounder, Todd M Bauer, Gary K Schwartz, et al.
Pageof 122

Showing results (1061-1070 of 1,220) with videos related to

Sort By:
Pageof 122
Journal of Cancer Research and Clinical Oncology|April 4, 2023
Invasiveness assessment by artificial intelligence against intraoperative frozen section for pulmonary nodules ≤ 3 cmZe-Rui Zhao, Ying-Hong Yu, Zhi-Chao Lin, et al.
Briefings in Bioinformatics|January 29, 2019
Clinical trials, progression-speed differentiating features and swiftness rule of the innovative targets of first-in-class drugsYing Hong Li, Xiao Xu Li, Jia Jun Hong, et al.
Journal of Cancer|March 24, 2020
MicroRNA-19a-3p regulates cell growth through modulation of the PIK3IP1-AKT pathway in hepatocellular carcinomaHai-Xiang Sun, Zhang-Fu Yang, Wei-Guo Tang, et al.
Neural Regeneration Research|October 23, 2019
Protective effects of organic extracts of <i>Alpinia oxyphylla</i> against hydrogen peroxide-induced cytotoxicity in PC12 cellsLi-Hong Duan, Meng Li, Chun-Bao Wang, et al.
Frontiers in Immunology|July 9, 2024
Circulating immune and plasma biomarkers of time to HIV rebound in HIV controllers treated with vesatolimodMohamed Abdel-Mohsen, Steven Deeks, Leila Giron, et al.
Circulation Research|June 19, 2010
Nitro-oleic acid inhibits angiotensin II-induced hypertensionJifeng Zhang, Luis Villacorta, Lin Chang, et al.
International Journal of Oncology|November 15, 2016
Lamp2a is required for tumor growth and promotes tumor recurrence of hepatocellular carcinomaZhen-Bin Ding, Xiu-Tao Fu, Ying-Hong Shi, et al.
Cell Death & Disease|June 30, 2017
MicroRNA-29a induces loss of 5-hydroxymethylcytosine and promotes metastasis of hepatocellular carcinoma through a TET-SOCS1-MMP9 signaling axisQing Chen, Dan Yin, Yong Zhang, et al.
Cancer|September 3, 2015
Role of a serum-based biomarker panel in the early diagnosis of lung cancer for a cohort of high-risk patientsDa-Wei Yang, Yong Zhang, Qun-Ying Hong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2023
A First-in-Human Phase I Study of Milademetan, an MDM2 Inhibitor, in Patients With Advanced Liposarcoma, Solid Tumors, or LymphomasMrinal M Gounder, Todd M Bauer, Gary K Schwartz, et al.
Pageof 122